Published in Int Urol Nephrol on November 30, 2011
Angiotensin-converting enzyme inhibitor, angiotensin receptor blocker use, and mortality in patients with chronic kidney disease. J Am Coll Cardiol (2013) 1.91
Glycemic control and cardiovascular mortality in hemodialysis patients with diabetes: a 6-year cohort study. Diabetes (2012) 1.33
Invasive methicillin-resistant Staphylococcus aureus infections among patients on chronic dialysis in the United States, 2005-2011. Clin Infect Dis (2013) 1.02
Relative contributions of inflammation and inadequate protein intake to hypoalbuminemia in patients on maintenance hemodialysis. Int Urol Nephrol (2012) 0.94
Comorbidity burden at dialysis initiation and mortality: A cohort study. Can J Kidney Health Dis (2015) 0.83
A self-report comorbidity questionnaire for haemodialysis patients. BMC Nephrol (2014) 0.82
Significant unmet oral health needs of homebound elderly adults. J Am Geriatr Soc (2014) 0.78
Developing a framework for evaluating kidney transplantation candidacy in children with multiple comorbidities. Pediatr Nephrol (2014) 0.77
Prediction of Mortality in Incident Hemodialysis Patients: A Validation and Comparison of CHADS2, CHA2DS2, and CCI Scores. PLoS One (2016) 0.76
Correlates of low hemoglobin A1c in maintenance hemodialysis patients. Int Urol Nephrol (2012) 0.76
Association of the Charlson comorbidity index with renal outcome and all-cause mortality in antineutrophil cytoplasmatic antibody-associated vasculitis. Medicine (Baltimore) (2014) 0.75
Screening Women with CKD for the Emperor of All Maladies. Clin J Am Soc Nephrol (2016) 0.75
Simple, readily available clinical indices predict early and late mortality among patients with ANCA-associated vasculitis. BMC Nephrol (2017) 0.75
Predicting mortality from change-over-time in the Charlson Comorbidity Index: A retrospective cohort study in a data-intensive UK health system. Medicine (Baltimore) (2016) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med (2002) 16.23
The biology of cachectin/TNF--a primary mediator of the host response. Annu Rev Immunol (1989) 9.63
Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol (2003) 4.28
Influence of coexisting disease on survival on renal-replacement therapy. Lancet (1993) 4.12
A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med (2000) 3.96
Is there a rationale for rationing chronic dialysis? A hospital based cohort study of factors affecting survival and morbidity. BMJ (1999) 2.93
The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol (2008) 2.80
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2010) 2.68
Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr (2006) 2.67
Excerpts from the United States Renal Data System 2006 Annual Data Report. Am J Kidney Dis (2007) 2.16
Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant (2005) 2.16
United States Renal Data System 2008 Annual Data Report. Am J Kidney Dis (2009) 2.14
Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant (2002) 2.05
Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol (2007) 1.92
Comorbidity assessment in hemodialysis and peritoneal dialysis using the index of coexistent disease. Semin Dial (2001) 1.79
Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis (1995) 1.74
Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol (2006) 1.73
Associations between chronic disease, age and physical and mental health status. Chronic Dis Can (2009) 1.71
Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol (2007) 1.64
Association of soluble endotoxin receptor CD14 and mortality among patients undergoing hemodialysis. Am J Kidney Dis (2009) 1.52
Charlson comorbidity index as a predictor of outcomes in incident peritoneal dialysis patients. Am J Kidney Dis (2001) 1.49
How to adjust for comorbidity in survival studies in ESRD patients: a comparison of different indices. Am J Kidney Dis (2002) 1.49
Predicting 1 year mortality in an outpatient haemodialysis population: a comparison of comorbidity instruments. Nephrol Dial Transplant (2004) 1.46
A user's guide to selecting a comorbidity index for clinical research. J Clin Epidemiol (2006) 1.45
Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients. Clin J Am Soc Nephrol (2010) 1.45
The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: overview of the NIED study and the role of dietitians. J Ren Nutr (2005) 1.39
Survival in patients with end-stage renal disease. Am J Kidney Dis (1991) 1.28
Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol (2010) 1.25
Near infra-red interactance for nutritional assessment of dialysis patients. Nephrol Dial Transplant (1999) 1.19
Diagnostic value of CRP and Lp(a) in coronary heart disease. Acta Cardiol (2002) 1.19
Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis (2010) 1.16
Charlson Comorbidity Index is a predictor of outcomes in incident hemodialysis patients and correlates with phase angle and hospitalization. Int J Artif Organs (2004) 1.13
The need for reappraisal of AIDS score weight of Charlson comorbidity index. J Clin Epidemiol (2007) 1.12
Influence of co-morbidity on mortality and morbidity in patients treated with hemodialysis. Am J Kidney Dis (1994) 1.08
Anthropometric norms for the dialysis population. Am J Kidney Dis (1990) 1.05
Body composition, treatment time, and outcome in hemodialysis patients. J Ren Nutr (1999) 1.03
Comorbidity: the major challenge for survival and quality of life in end-stage renal disease. Nephrol Dial Transplant (1998) 0.93
Among older adults, the responsiveness of self-rated health to changes in Charlson comorbidity was moderated by age and baseline comorbidity. J Clin Epidemiol (2008) 0.89
The disproportionate burden of kidney disease in those who can least afford it. Kidney Int Suppl (2005) 0.89
Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med (2010) 8.48
Cachexia: a new definition. Clin Nutr (2008) 5.49
Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients. Kidney Int (2003) 5.37
Kidney-Failure Risk Projection for the Living Kidney-Donor Candidate. N Engl J Med (2015) 5.03
Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med (2008) 4.98
US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis (2015) 3.94
Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences. Am J Kidney Dis (2003) 3.90
Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med (2010) 3.78
Long-term effects of renin-angiotensin system-blocking therapy and a low blood pressure goal on progression of hypertensive chronic kidney disease in African Americans. Arch Intern Med (2008) 3.71
Pure red-cell aplasia and epoetin therapy. N Engl J Med (2004) 3.49
Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation (2009) 3.43
Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis (2008) 3.34
Body mass index and mortality in heart failure: a meta-analysis. Am Heart J (2008) 3.25
Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States. Am J Med (2003) 2.94
Associations between changes in hemoglobin and administered erythropoiesis-stimulating agent and survival in hemodialysis patients. J Am Soc Nephrol (2006) 2.89
Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med (2013) 2.74
Blood pressure components and end-stage renal disease in persons with chronic kidney disease: the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2012) 2.74
Erythropoietin, iron depletion, and relative thrombocytosis: a possible explanation for hemoglobin-survival paradox in hemodialysis. Am J Kidney Dis (2008) 2.74
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol (2010) 2.68
Associations of body fat and its changes over time with quality of life and prospective mortality in hemodialysis patients. Am J Clin Nutr (2006) 2.67
Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol (2009) 2.61
Does AKI truly lead to CKD? J Am Soc Nephrol (2012) 2.61
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality. J Am Soc Nephrol (2011) 2.59
The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis. Mayo Clin Proc (2010) 2.55
Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int (2009) 2.52
Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population. Am J Kidney Dis (2005) 2.47
Race, gender, and socioeconomic disparities in CKD in the United States. J Am Soc Nephrol (2008) 2.43
Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc (2011) 2.34
Building an academic-community partnered network for clinical services research: the Community Health Improvement Collaborative (CHIC). Ethn Dis (2006) 2.25
Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis (2009) 2.25
A comparative effectiveness research study of the change in blood pressure during hemodialysis treatment and survival. Kidney Int (2013) 2.23
Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease? Am J Clin Nutr (2008) 2.22
Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2010) 2.18
Phosphorus and risk of renal failure in subjects with normal renal function. Am J Med (2013) 2.18
Revisiting mortality predictability of serum albumin in the dialysis population: time dependency, longitudinal changes and population-attributable fraction. Nephrol Dial Transplant (2005) 2.16
Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease. Nephrol Dial Transplant (2006) 2.15
Independent components of chronic kidney disease as a cardiovascular risk state: results from the Kidney Early Evaluation Program (KEEP). Arch Intern Med (2007) 2.14
Health insurance status and hypertension monitoring and control in the United States. Am J Hypertens (2007) 2.09
Racial and survival paradoxes in chronic kidney disease. Nat Clin Pract Nephrol (2007) 2.06
Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol (2008) 2.05
Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol (2007) 2.05
Is an increased serum bicarbonate concentration during hemodialysis associated with an increased risk of death? Semin Dial (2014) 2.02
The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int (2009) 1.98
Association of disorders in mineral metabolism with progression of chronic kidney disease. Clin J Am Soc Nephrol (2006) 1.95
Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol (2007) 1.92
Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl (2010) 1.91
Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients. Clin J Am Soc Nephrol (2011) 1.90
The obesity paradox in the elderly: potential mechanisms and clinical implications. Clin Geriatr Med (2009) 1.89
Outcomes associated with microalbuminuria: effect modification by chronic kidney disease. J Am Coll Cardiol (2013) 1.89
Comparison of the CKD Epidemiology Collaboration (CKD-EPI) and Modification of Diet in Renal Disease (MDRD) study equations: risk factors for and complications of CKD and mortality in the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis (2011) 1.88
The associations between race and geographic area and quality-of-care indicators in patients approaching ESRD. Clin J Am Soc Nephrol (2013) 1.87
Hyponatremia, hypernatremia, and mortality in patients with chronic kidney disease with and without congestive heart failure. Circulation (2012) 1.86
Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol (2009) 1.85
Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr (2013) 1.85
Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am J Clin Nutr (2009) 1.83
Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD. Am J Kidney Dis (2010) 1.82
Risk factor paradox in wasting diseases. Curr Opin Clin Nutr Metab Care (2007) 1.82
Age and the associations of living donor and expanded criteria donor kidneys with kidney transplant outcomes. Am J Kidney Dis (2012) 1.81
Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension (2005) 1.80
Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients. Am J Kidney Dis (2009) 1.79
Impact of race on hyperparathyroidism, mineral disarrays, administered vitamin D mimetic, and survival in hemodialysis patients. J Bone Miner Res (2010) 1.79
Association of Malnutrition-Inflammation Score with quality of life and mortality in hemodialysis patients: a 5-year prospective cohort study. Am J Kidney Dis (2008) 1.78